Skip to main content
. 2024 Oct 25;25:379. doi: 10.1186/s12882-024-03763-z

Table 1.

Selection criteria

Inclusion criteria: Exclusion criteria:
Population

Adults aged 18 and over

People with diabetes mellitus and end stage kidney disease on long term dialysis (peritoneal or haemodialysis)

Receiving glucose lowering medication

Chronic kidney disease not receiving dialysis

Acute Kidney injury

Study design

Randomised clinical trials, clinical trials and observational studies. Minimum follow up duration of 6 weeks

Minimum sample size 10 participants

Other study designs: case study, case series and review articles
Intervention Continuous Glucose Monitoring (isCGM and rtCGM)
Outcomes

Primary outcomes: overall glycaemic control determined by Time in Range (TIR), Time Above Range (TAR) and Time Below Range (TBR)

Secondary outcomes: estimated HbA1c, episodes of severe hypoglycemia, number of hospitalisations, patient compliance with glucose scanning, quality of life

Other outcome measures
Others

Published in English language

Papers published in peer-reviewed-journals

Articles published before year 1999